HowShorted

How shorted is Praxis Precision Medicines, Inc.?

More shorted than 88% of the 2,877 ranked US companies

13.10%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
−0.40
5 reports (~10 weeks)
−0.20
Aggregate net short position time series for Praxis Precision Medicines, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202613.10%−0.40
15 Jul 202613.50%−0.80
30 Jun 202614.30%+1.50
15 Jun 202612.80%−0.30
29 May 202613.10%−0.20
15 May 202613.30%−1.80
30 Apr 202615.10%−0.01
15 Apr 202615.11%−0.70
31 Mar 202615.81%+0.84
13 Mar 202614.97%−0.17
27 Feb 202615.14%−0.04
13 Feb 202615.18%−0.25
30 Jan 202615.43%+0.44
15 Jan 202614.99%−0.05
31 Dec 202515.04%+0.36
15 Dec 202514.68%+0.48
28 Nov 202514.20%−0.25
14 Nov 202514.45%+2.22
31 Oct 202512.23%−0.18
15 Oct 202512.41%−0.12
30 Sep 202512.53%+1.20
15 Sep 202511.33%+0.10
29 Aug 202511.23%+0.15
15 Aug 202511.08%+1.00
31 Jul 202510.08%–

Frequently asked questions

How shorted is Praxis Precision Medicines, Inc. right now?
13.10% of Praxis Precision Medicines, Inc.'s (PRAX) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.